| HepG2 | 
Caption: IP-Western Blot analysis of HepG2 whole cell lysate using XRCC5 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 10% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-XRCC5 antibody (lanes under 'XRCC5'). Method: immunoprecipitation Status: Released Lab: Yeo Lab | 
Caption: Western blot following shRNA against XRCC5 in HepG2 whole cell lysate using XRCC5 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against XRCC5. XRCC5 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGHLV14-67 Status: Released Lab: Graveley Lab |
|---|
| K562 | 
Caption: IP-Western Blot analysis of K562 whole cell lysate using XRCC5 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 10% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-XRCC5 antibody (lanes under 'XRCC5'). Method: immunoprecipitation Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against XRCC5 in K562 whole cell lysate using XRCC5 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against XRCC5. XRCC5 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow. Releated Sample: BGKcLV11-111 Status: Released Lab: Graveley Lab |
|---|